Sponsor of the Day:
Jerkmate
https://www.mskcc.org/research-areas/topics/hematologic-malignancies
Hematologic Malignancies | Memorial Sloan Kettering Cancer Center
Learn about the work Memorial Sloan Kettering scientists are doing in the area of hematologic malignancies.
memorial sloan ketteringhematologic malignanciescancer center
https://diagnostics.roche.com/global/en/products/product-category/health-topic/oncology/blood-cancer.html
Blood cancers (hematologic malignancies)
Roche’s comprehensive portfolio of hematopathology solutions helps drive diagnostic certainty for blood cancers and hematologic malignancies including lymphoma.
blood cancershematologic malignancies
https://www.fda.gov/drugs/resources-information-approved-drugs/oncology-cancerhematologic-malignancies-approval-notifications
Oncology (Cancer)/Hematologic Malignancies Approval Notifications | FDA
FDA does not issue approval announcements for every approval or drug label update that occurs in oncology and hematology. Please refer to Drugs@FDA for the...
oncology cancerhematologic malignanciesapprovalnotificationsfda
https://www.dana-farber.org:443/for-physicians/clinical-resources/hematologic-malignancies
Hematologic Malignancies Resources and Support | Dana-Farber Cancer Institute
Find out how we partner with referring providers to provide more patients access to the most advanced care and treatment available for hematologic...
support dana farberhematologic malignanciescancer instituteresources
https://www.frontiersin.org/journals/oncology/sections/hematologic-malignancies
Frontiers in Oncology | Hematologic Malignancies
Explore global open-access research on hematologic malignancies, advancing understanding and treatment of blood cancers through clinical and molecular studies.
hematologic malignanciesfrontiersoncology
https://www.dana-farber.org/for-physicians/clinical-resources/hematologic-malignancies/advances-newsletter/2025-issue-21
Advances in Hematologic Malignancies Issue 21, Fall 2025 | Dana-Farber Cancer Institute
Stay up to date on the latest research and clinical advances in hematologic malignancies with Dana-Farber's Fall 2025 newsletter.
dana farber cancerhematologic malignanciesissue 21fall 2025advances